APA

Cabeza L., Ortiz R., Prados J., Delgado Á. V., Martín-Villena M. J., Clares B., Perazzoli G., Entrena J. M., Melguizo C. & Arias J. L. (20180302). Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. : European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Chicago

Cabeza Laura, Ortiz Raul, Prados Jose, Delgado Ángel V, Martín-Villena Maria J, Clares Beatriz, Perazzoli Gloria, Entrena Jose M, Melguizo Consolación and Arias Jose L. 20180302. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. : European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Harvard

Cabeza L., Ortiz R., Prados J., Delgado Á. V., Martín-Villena M. J., Clares B., Perazzoli G., Entrena J. M., Melguizo C. and Arias J. L. (20180302). Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. : European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

MLA

Cabeza Laura, Ortiz Raul, Prados Jose, Delgado Ángel V, Martín-Villena Maria J, Clares Beatriz, Perazzoli Gloria, Entrena Jose M, Melguizo Consolación and Arias Jose L. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. : European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 20180302.